The increasing complexity of malignant diseases treatment necessitates a comprehensive understanding of different healthcare systems. This article aims to explore the strengths and weaknesses of transatlantic cancer care, contrasting the practices in both the United States and the European Union. Through a multifaceted lens, we will review key fact